Curious to see your top suppliers emissions?
Book a demo for a pilot project
GSL Biotech LLC, commonly known for its flagship product SnapGene, is a leading provider of molecular biology software solutions headquartered in the United States. Founded in 2013, the company has rapidly established itself in the biotechnology industry, focusing on enhancing DNA sequence visualisation and analysis for researchers worldwide.
With a commitment to innovation, GSL Biotech offers unique tools that simplify the design and documentation of molecular cloning experiments. Their software is widely recognised for its user-friendly interface and powerful features, making it an essential resource for scientists in academic and commercial laboratories alike.
GSL Biotech's dedication to quality and customer satisfaction has positioned it as a trusted partner in the life sciences sector, contributing to significant advancements in genetic research and biotechnology applications.
100
DitchCarbon score
+70 vs industry average
GSL Biotech LLC’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at GSL Biotech LLC?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Research Services has below-average carbon intensity
Industry performance
0.198
20182025
The Research Services industry has reduced its overall emissions by 19% since 2018
Reported emissions
No reported emissions data is available for GSL Biotech LLC yet.
GSL Biotech LLC's reported carbon emissions
GSL Biotech LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Siemens Aktiengesellschaft, GSL Biotech's climate commitments and initiatives are influenced by its parent company's sustainability strategies.
While no absolute emissions figures are provided, GSL Biotech is aligned with several significant climate initiatives cascaded from Siemens. These include participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all aimed at reducing carbon footprints and promoting renewable energy usage.
GSL Biotech's commitment to sustainability reflects the broader industry trend towards transparency and accountability in climate action, although specific reduction targets or achievements have not been disclosed. The company is expected to adhere to the ambitious climate goals set forth by Siemens, which are designed to mitigate climate change impacts and promote environmental stewardship.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
GSL Biotech LLC’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for GSL Biotech LLC yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Siemens AktiengesellschaftSee details
Not active
Carbon Disclosure Project
Inherited from Siemens AktiengesellschaftSign in to view
Active
The Climate Pledge
Inherited from Siemens AktiengesellschaftSee details
Not active
UN Global Compact Climate Champions initiative
Inherited from Siemens AktiengesellschaftSee details
Not active
RE 100
Inherited from Siemens AktiengesellschaftSee details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for GSL Biotech LLC yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more